Combining existing drug therapy is essential in developing new therapeutic agents in
disease prevention and treatment. In preclinical investigations, combined effect of certain …

Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …

Messenger RNA (mRNA) is the template for protein biosynthesis and is emerging as an
essential active molecule to combat various diseases, including viral infection and cancer …

Stroke is a common disease and is the major cause of death and disability. It occurs and
generates devastating neurological deficits when cerebral blood vessel is blocked (ischemic …

Adoptive immunotherapy expressing synthetic chimeric antigen receptors (CAR) on T cells
through in vitro modifications represents a new and innovative strategy in cancer treatment …

The consumption of non-steroidal anti-inflammatory drugs (NSAIDs) have increased
significantly in the last years (2020–2022), especially for patients in COVID-19 treatment …

COVID-19 has been found to affect the expression profile of several mRNAs and miRNAs,
leading to dysregulation of a number of signaling pathways, particularly those related to …

Particle-based drug delivery systems have shown promising application potential to treat
human diseases; however, an incomplete understanding of their interactions with vascular …

Simple Summary We reviewed the medical applications of low-dose radiation therapy
(LDRT) in cancer and inflammatory and degenerative diseases by proposing a unified …

With the outbreak and pandemic of coronavirus disease‐2019 (COVID‐19), a huge number
of people died of it. Apart from lung injuries, multiple organs have been confirmed to be …